The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis.

<h4>Importance</h4>A number of officially approved disease-modifying drugs (DMD) are currently available for the early intervention in patients with relapsing-remitting multiple sclerosis (RRMS). The aim of the present study was to systematically evaluate the effect of DMDs on disability...

Full description

Saved in:
Bibliographic Details
Main Authors: Georgios Tsivgoulis, Aristeidis H Katsanos, Nikolaos Grigoriadis, Georgios M Hadjigeorgiou, Ioannis Heliopoulos, Panagiotis Papathanasopoulos, Constantinos Kilidireas, Konstantinos Voumvourakis, Efthimios Dardiotis, HELANI (Hellenic Academy of Neuroimmunology)
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0144538&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!